Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Schizophrenia (17)
- Psychosis (9)
- Depression (5)
- Mumbai (4)
- Suicide (4)
-
- Risk assessment (3)
- Antidepressant (2)
- Cannabis (2)
- Early intervention (2)
- Mental health (2)
- Antipsychotic drug (1)
- Antipsychotic drugs (1)
- Antipsychotics (1)
- Assessment (1)
- Atypical Antipsychotics (1)
- Atypical antipsychotic (1)
- Brain (1)
- Catatonia (1)
- Clinical assessment (1)
- Clinical interview (1)
- Clinical psychiatry (1)
- Cognition (1)
- Cognitive enhancement (1)
- Comorbidity (1)
- Crisis (1)
- DSM V (1)
- Diagnosis (1)
- Duration of untreated psychosis (1)
- Early psychosis (1)
- Health (1)
Articles 1 - 30 of 39
Full-Text Articles in Medicine and Health Sciences
Brain Maturation, Poverty And Social Exclusion: Shifting Paradigms Of Psychopathology, Amresh Srivastava
Brain Maturation, Poverty And Social Exclusion: Shifting Paradigms Of Psychopathology, Amresh Srivastava
Psychiatry Presentations
Abstract for lecture
Poverty is a major risk factor for mental disorders. Neuroimaging studies show path are breaking findings to explain why ppeople living in poverty suffer from improper development and maturation of brain due to neuronal loss. It sets in much before the child is born and leads to increased vulnerability for mental disorders.
Recent findings show that changes in brain structure and function due to lack of brain maturation is directly related to poverty. A number of these changes are end result of neuronal survival in the most fundamental neuronal matrix. These findings along with other biological correlates …
Beyond Early Intervention, Amresh Srivastava
Beyond Early Intervention, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Psychoendocrinology (Thyroid Hormone) And Early Psychosis: Preliminary Findings, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell
Psychoendocrinology (Thyroid Hormone) And Early Psychosis: Preliminary Findings, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell
Psychiatry Presentations
No abstract provided.
Serum Lipids And Suicidality In Early Psychosis: Is There A Connection? A Preliminary Study, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell
Serum Lipids And Suicidality In Early Psychosis: Is There A Connection? A Preliminary Study, Amresh Srivastava, Megan Johnston, Lenore Purde, Robbie Campbell
Psychiatry Presentations
No abstract provided.
Should 'Risk Syndrome Of Psychosis' Be Included In Dsm V As A Diagnosis? A Road Towards Preventive Psychiatry, Amresh Srivastava
Should 'Risk Syndrome Of Psychosis' Be Included In Dsm V As A Diagnosis? A Road Towards Preventive Psychiatry, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Enhancing Risk Assessment Across Mental Health Services, Amresh Srivastava, Megan Johnston, Charles Nelson
Enhancing Risk Assessment Across Mental Health Services, Amresh Srivastava, Megan Johnston, Charles Nelson
Psychiatry Presentations
No abstract provided.
Antipsychotics And Outcome In Schizophrenia, Amresh Srivastava, Anukant Mital
Antipsychotics And Outcome In Schizophrenia, Amresh Srivastava, Anukant Mital
Psychiatry Presentations
No abstract provided.
Predictors And Characteristics Of Response And Nonresponse: A Ten Year Follow-Up Of First Episode Schizophrenia In Mumbai, Amresh Shrivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy
Predictors And Characteristics Of Response And Nonresponse: A Ten Year Follow-Up Of First Episode Schizophrenia In Mumbai, Amresh Shrivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy
Psychiatry Presentations
▪ It is not clearly known what predicts good long-term outcome in first episode schizophrenia and what the characteristics are that differentiate patients who do and do not show good response
▪ We attempted to find the characteristics and predictors of good out-come for patients who presented with severe psychopathology and were hospitalized in their first episode psychosis in a tertiary psychiatric hospital in the city of Mumbai
▪ 101 patients of first episode schizophrenia were assessed at hospitalization, and reassessed at ten years
▪ The data was analyzed on 13 outcome parameters for predictors and characteristics of good outcome, …
Do Atypical Antipsychotics Differ In Determining Long-Term Outcome Of First Episode Schizophrenia? A Naturalistic Outcome Study In India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Anukant Mital
Do Atypical Antipsychotics Differ In Determining Long-Term Outcome Of First Episode Schizophrenia? A Naturalistic Outcome Study In India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Anukant Mital
Psychiatry Presentations
Antipsychotic medications form the mainstream of treatment in schizophrenia. These drugs have several short term as well long term advantage. It is not known if atypical antipsychotics have the long-term effect in improving outcome and meeting expectations (1,2,3). The present study examined usage and association of antipsychotics drugs with clinical outcome a long-term naturalistic study.
Current Understanding And Pharmacological Management Of Suicide Behavior In Clinical Setting, Amresh Shrivastava
Current Understanding And Pharmacological Management Of Suicide Behavior In Clinical Setting, Amresh Shrivastava
Psychiatry Presentations
This presentation addresses these issues:
• Nature of problem in clinical settings
• Current understanding about suicide behavior (neurobiology)
• What can be done to deal with suicide in clinical settings
• Pharmacological management
Early Psychosis: A Novel Gateway For Suicide Prevention, Amresh Srivastava
Early Psychosis: A Novel Gateway For Suicide Prevention, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava
Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Switching And Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava
Switching And Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 1), Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava
Selecting Antidepressant Drugs For Management Of Depression In Primary Care (Part 2), Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava
Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Psychiatry Presentations
Serum prolactinis an indicator of tuberoinfundibulardopamine activity. It is reported to increase in wide variety of mental illnesses. It has close relationship with antipsychotic therapy. However, its relationship with psychopathology and outcome is not clear. Serum prolactinlevel was measured in 30 male and 30 female drug naive patients of schizophrenia. Subsequently, these patients were treated with antipsychotics. The severity of psychopathology at the baseline and subsequent improvement at the end of 3 weeks and 6 weeks was assessed on modified brief psychiatric rating scale (mBPRS). Available to follow up at five years 18 males & 22 females patients were reassessed …
Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson
Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson
Psychiatry Presentations
No abstract provided.
Treatment Resistant Depression, Amresh Srivastava
Treatment Resistant Depression, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
First Episode Is The Best Episode: Lessons And Limitations In Duration Of Untreated Psychosis (Dup) And Outcome In Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Nilesh Shah
First Episode Is The Best Episode: Lessons And Limitations In Duration Of Untreated Psychosis (Dup) And Outcome In Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Nilesh Shah
Psychiatry Presentations
Background: Early intervention in psychosis is an opportunity. Research ahs shown that if any thing community members can do to prevent psychosis is to report early. This has opened newer vistas for understanding the complexity of brain and behaviour in schizophrenia. At the same time it has raised the bar of expectations regarding its correlation to outcome. It finally narrows down to meaningful public campaign for awareness, which will decide success of research to clinics in schizophrenia management. Duration of untreated psychosis (DUP) has emerged as a reliable predictor of outcome and provides credence to development of early intervention services. …
Clinical Interview For Psychiatric Assessment, Amresh Srivastava
Clinical Interview For Psychiatric Assessment, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava
Interface Of Cannabis And Early Psychosis--Priorities In Research And Service Development, Amresh Srivastava
Psychiatry Presentations
Introduction: cannabis continues to affect mental health. Its abuse is on rise globally. In Canada a rise by 30% in last ten years has been observed in high school students. Interrelationship of cannabis with psychosis and schizophrenia is a complex one. Cannabis is highly comorbid with psychosis, & related to functional disability and outcome. It poses several challenges in understanding causal relationship for comorbidity, underlying neurochemical basis and specifics of service development. Prevalence of Cannabis varies from 20 to 50% early psychosis. Objective of this paper is to review available literature to identify challenges for newer targets of research and …
Cannabis & Psychosis: The Interface Emerging Frontiers For Research, Amresh Shrivastava
Cannabis & Psychosis: The Interface Emerging Frontiers For Research, Amresh Shrivastava
Psychiatry Presentations
INTRODUCTION: CANNABIS CONTINUES TO AFFECT MENTAL HEALTH. ITS ABUSE IS ON RISE GLOBALLY. IN CANADA A RISE BY 30% IN LAST TEN YEARS HAS BEEN OBSERVED IN HIGH SCHOOL STUDENTS. INTERRELATIONSHIP OF CANNABIS WITH PSYCHOSIS AND SCHIZOPHRENIA IS A COMPLEX ONE. CANNABIS IS HIGHLY COMORBID WITH PSYCHOSIS, & RELATED TO FUNCTIONAL DISABILITY AND OUTCOME. IT POSES SEVERAL CHALLENGES IN UNDERSTANDING CAUSAL RELATIONSHIP FOR COMORBIDITY, UNDERLYING NEUROCHEMICAL BASIS AND SPECIFICS OF SERVICE DEVELOPMENT. PREVALENCE OF CANNABIS VARIES FROM 20 TO 50% EARLY PSYCHOSIS. OBJECTIVE OF THIS PAPER IS TO REVIEW AVAILABLE LITERATURE TO IDENTIFY CHALLENGES FOR NEWER TARGETS OF RESEARCH AND …
Differential Characteristics Of “Good Outcome Schizophrenia” In A Long-Term Ten Years Study, Mumbai, India, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Differential Characteristics Of “Good Outcome Schizophrenia” In A Long-Term Ten Years Study, Mumbai, India, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Psychiatry Presentations
No abstract provided.
Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson
Coping With Clinical Challenges Of Risk Assessment: Towards A New Comprehensive Instrument, Amresh Srivastava, Charles Nelson
Psychiatry Presentations
No abstract provided.
Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava
Coping With Clinical Challenges Of Risk-Assessment, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Outcome In Schizophrenia: The Long-Term Good Outcome In Schizophrenia Is Not Yet Good Enough, Amresh Srivastava, Meghan Thakar
Outcome In Schizophrenia: The Long-Term Good Outcome In Schizophrenia Is Not Yet Good Enough, Amresh Srivastava, Meghan Thakar
Psychiatry Presentations
The illness of schizophrenia has always been a matter of concern for its nature and extent of outcome particularly for its regional and cultural differences. The concept of outcome has been evolving and this study examines the scenario of good outcome in developing countries.
Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Outcome In Schizophrenia: How Good Is "Good Outcome" Schizophrenia In Long-Term In Developing Countries, Amresh Srivastava, Meghan Thakar, Nilesh Shah, Larry Stitt
Psychiatry Presentations
No abstract provided.
Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava
Complexity And Limitations Of Stress-Endocrine Research In Mental Health, Amresh Srivastava
Psychiatry Presentations
No abstract provided.